Hadron Labs launches 'Bitcoin Summer' on Neutron, BTC vaults for WBTC, eBTC, solvBTC, uniBTC and USDC. Earn 5–10% BTC via maxBTC, with up to 10x looping.Hadron Labs launches 'Bitcoin Summer' on Neutron, BTC vaults for WBTC, eBTC, solvBTC, uniBTC and USDC. Earn 5–10% BTC via maxBTC, with up to 10x looping.

Hadron Labs Launches Bitcoin Summer on Neutron, Offering 5–10% BTC Yield

2025/09/18 02:00
neutron

Hadron Labs, the core team behind the Neutron blockchain, today launched Bitcoin Summer, a BTC-focused yield campaign that brings established DeFi yield strategies, including leveraged looping, to Bitcoin holders at scale.

Starting now, BTC holders can deposit WBTC, eBTC, solvBTC, uniBTC and USDC into a selection of Bitcoin Summer vaults tailored by yield, risk and asset preference. Those vaults feed lending markets and DEX liquidity that, in turn, enable leveraged BTC looping, a mainstay strategy in DeFi that until now has been largely inaccessible to BTC holders en masse.

At the heart of the campaign is maxBTC, an asset that tokenizes real BTC yield generated from both on- and off-chain strategies. Depositors into maxBTC can expect a base yield in the range of roughly 5–10% in BTC, and those who choose to take on leverage may loop their position up to 10x via borrowing.

As looping activity grows, vault depositors stand to capture additional upside from swap fees and lending income paid by loopers, creating a feedback loop of higher yields for liquidity providers.

“Lombard has consistently enabled people to connect their Bitcoin to DeFi, proven by an 82% LBTC utilization rate. We’re excited to bring LBTC to the Neutron DeFi ecosystem and leverage its unique DeFi components to unlock real yield for LBTC holders,” said Jacob Phillips, Co-founder of Lombard Finance.

Powered by Neutron

Neutron’s selling point is its bespoke infrastructure designed specifically to reduce risks that have dogged on-chain BTC liquidity provision. Bitcoin Summer vaults run on Neutron’s stack, which includes:

  • A high-frequency oracle that pulls the freshest prices so Supervaults can provide liquidity at the best available rates.
  • A cron module that guarantees top-of-block execution, preventing rebalancing transactions from being frontran and protecting LPs from adverse outcomes.
  • A native, fully on-chain orderbook to support efficient and transparent trading.

According to the campaign materials, these elements together mitigate adverse selection risk for BTC liquidity providers and deliver a more sustainable, “real yield” model for LPs compared with many existing on-chain options.

Neutron is a public proof-of-stake blockchain built to let BTC holders earn a sustainable yield through an expanding set of products and services. As demand for BTC yield on the network rises, the ecosystem design routes value back to NTRN stakers via transaction fees and through mechanisms that reduce circulating NTRN supply.

Hadron Labs, founded in 2022, is the core development team powering Neutron and related projects like Drop, Duality and Bull vs. Bear. The team bills itself as crypto-native, with members who have worked at Lido, P2P, Consensys, Uniswap, Balancer, Trader Joe and Delv.

Bitcoin Summer marks a noteworthy push to bridge Bitcoin liquidity into DeFi’s yield machinery. For BTC holders who have watched such strategies flourish on Ethereum and other chains, Neutron’s campaign offers a first-class entry point to on-chain BTC yield with a toolkit designed to reduce some of the traditional frictions and risks.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Share Insights

You May Also Like

The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29
Share